264 related articles for article (PubMed ID: 28780379)
21. Protective effect of boldine on oxidative mitochondrial damage in streptozotocin-induced diabetic rats.
Jang YY; Song JH; Shin YK; Han ES; Lee CS
Pharmacol Res; 2000 Oct; 42(4):361-71. PubMed ID: 10987997
[TBL] [Abstract][Full Text] [Related]
22. Graft-derived macrophage migration inhibitory factor correlates with hepatocellular injury in patients undergoing liver transplantation.
Baron-Stefaniak J; Schiefer J; Miller EJ; Plöchl W; Krenn CG; Berlakovich GA; Baron DM; Faybik P
Clin Transplant; 2017 Jun; 31(6):. PubMed ID: 28370484
[TBL] [Abstract][Full Text] [Related]
23. Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells.
Stojanović I; Cvjetićanin T; Lazaroski S; Stosić-Grujicić S; Miljković D
Immunology; 2009 Jan; 126(1):74-83. PubMed ID: 18624729
[TBL] [Abstract][Full Text] [Related]
24. MIF induces osteoclast differentiation and contributes to progression of periodontal disease in mice.
Madeira MF; Queiroz-Junior CM; Costa GM; Santos PC; Silveira EM; Garlet GP; Cisalpino PS; Teixeira MM; Silva TA; Souza Dda G
Microbes Infect; 2012 Feb; 14(2):198-206. PubMed ID: 22016007
[TBL] [Abstract][Full Text] [Related]
25. The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation.
Atsumi T; Cho YR; Leng L; McDonald C; Yu T; Danton C; Hong EG; Mitchell RA; Metz C; Niwa H; Takeuchi J; Onodera S; Umino T; Yoshioka N; Koike T; Kim JK; Bucala R
J Immunol; 2007 Oct; 179(8):5399-406. PubMed ID: 17911626
[TBL] [Abstract][Full Text] [Related]
26. Deletion of macrophage migration inhibitory factor ameliorates inflammation in mice model severe acute pancreatitis.
Zhu C; Liu Y; Song Y; Wang Q; Liu Y; Yang S; Li D; Zhang Y; Cheng B
Biomed Pharmacother; 2020 May; 125():109919. PubMed ID: 32062385
[TBL] [Abstract][Full Text] [Related]
27. Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease.
Li SQ; Yu Y; Han JZ; Wang D; Liu J; Qian F; Fan GH; Bucala R; Ye RD
J Neuroinflammation; 2015 Sep; 12():177. PubMed ID: 26382037
[TBL] [Abstract][Full Text] [Related]
28. IL-32γ overexpression accelerates streptozotocin (STZ)-induced type 1 diabetes.
Jhun H; Choi J; Hong J; Lee S; Kwak A; Kim E; Jo S; Ryoo S; Lim Y; Yoon DY; Hong JT; Kim TS; Lee Y; Song K; Kim S
Cytokine; 2014 Sep; 69(1):1-5. PubMed ID: 25022955
[TBL] [Abstract][Full Text] [Related]
29. P2X7 Receptor Expression in Peripheral Blood Monocytes Is Correlated With Plasma C-Reactive Protein and Cytokine Levels in Patients With Type 2 Diabetes Mellitus: a Preliminary Report.
Wu H; Nie Y; Xiong H; Liu S; Li G; Huang A; Guo L; Wang S; Xue Y; Wu B; Peng L; Song M; Li G; Liang S
Inflammation; 2015 Dec; 38(6):2076-81. PubMed ID: 26021292
[TBL] [Abstract][Full Text] [Related]
30. Gene knockout or inhibition of macrophage migration inhibitory factor alleviates lipopolysaccharide-induced liver injury via inhibiting inflammatory response.
Gu YL; Xiao LL; Li DJ; Liu YN; Zhu CJ; Zhang SJ
Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):469-477. PubMed ID: 34348873
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity suppresses microglia-mediated inflammatory responses.
Zhang Y; Gu R; Jia J; Hou T; Zheng LT; Zhen X
Clin Exp Pharmacol Physiol; 2016 Nov; 43(11):1134-1144. PubMed ID: 27543936
[TBL] [Abstract][Full Text] [Related]
32. Macrophage migration inhibitory factor deficiency augments doxorubicin-induced cardiomyopathy.
Xu X; Bucala R; Ren J
J Am Heart Assoc; 2013 Dec; 2(6):e000439. PubMed ID: 24334905
[TBL] [Abstract][Full Text] [Related]
33. Early release of macrophage migration inhibitory factor after liver ischemia and reperfusion injury in rats.
Liu A; Fang H; Dirsch O; Jin H; Dahmen U
Cytokine; 2012 Jan; 57(1):150-7. PubMed ID: 22136975
[TBL] [Abstract][Full Text] [Related]
34. Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection.
Assunção-Miranda I; Amaral FA; Bozza FA; Fagundes CT; Sousa LP; Souza DG; Pacheco P; Barbosa-Lima G; Gomes RN; Bozza PT; Da Poian AT; Teixeira MM; Bozza MT
FASEB J; 2010 Jan; 24(1):218-28. PubMed ID: 19776337
[TBL] [Abstract][Full Text] [Related]
35. The role of MIF in type 1 and type 2 diabetes mellitus.
Sánchez-Zamora YI; Rodriguez-Sosa M
J Diabetes Res; 2014; 2014():804519. PubMed ID: 24527464
[TBL] [Abstract][Full Text] [Related]
36. Macrophage migration inhibitory factor deficiency augments cardiac dysfunction in Type 1 diabetic murine cardiomyocytes.
Tong C; Morrison A; Yan X; Zhao P; Yeung ED; Wang J; Xie J; Li J
J Diabetes; 2010 Dec; 2(4):267-74. PubMed ID: 20923497
[TBL] [Abstract][Full Text] [Related]
37. Hepatocyte-derived macrophage migration inhibitory factor mediates alcohol-induced liver injury in mice and patients.
Marin V; Poulsen K; Odena G; McMullen MR; Altamirano J; Sancho-Bru P; Tiribelli C; Caballeria J; Rosso N; Bataller R; Nagy LE
J Hepatol; 2017 Nov; 67(5):1018-1025. PubMed ID: 28647568
[TBL] [Abstract][Full Text] [Related]
38. Prevention of multiple low-dose streptozotocin (MLD-STZ) diabetes in mice by an extract from gum resin of Boswellia serrata (BE).
Shehata AM; Quintanilla-Fend L; Bettio S; Singh CB; Ammon HP
Phytomedicine; 2011 Sep; 18(12):1037-44. PubMed ID: 21831620
[TBL] [Abstract][Full Text] [Related]
39. MIF 173 G>C variation was associated with depressive disorder in type 2 diabetes in an Iranian population.
Hamidi AK; Arzaghi SM; Qorbani M; Khatami F; Ebrahimi M; Bandarian F; Enayati S; Amoli MM
Psychoneuroendocrinology; 2019 Jun; 104():243-248. PubMed ID: 30903991
[TBL] [Abstract][Full Text] [Related]
40. Antidiabetic effect of total flavonoids from Sanguis draxonis in type 2 diabetic rats.
Chen F; Xiong H; Wang J; Ding X; Shu G; Mei Z
J Ethnopharmacol; 2013 Oct; 149(3):729-36. PubMed ID: 23933499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
